Search
for
Sort by
Research 691–720 of 1000+
- Safety of 5α-reductase inhibitors and spironolactone in breast cancer patients receiving endocrine therapies
- Urban Rural Comparisons of Polycystic Ovary Syndrome Burden among Adolescent Girls in a Hospital Setting in India
- Acne severity and the Global Acne Grading System in polycystic ovary syndrome
- The Hirsute Woman: Challenges in Evaluation and Management
- Is it Necessary to Measure Free Testosterone to Assess Hyperandrogenemia in Women? The Role of Calculated Free and Bioavailable Testosterone
- Managing Cutaneous Manifestations of Hyperandrogenic Disorders
- Androgenic effects of oral contraceptives: Implications for patient compliance
- Effects of finasteride, a 5 alpha-reductase inhibitor, on circulating androgens and gonadotropin secretion in hirsute women.
- Dermatologic Conditions in Transgender Populations
- Comorbid conditions in lichen planopilaris: A retrospective data analysis of 334 patients
- Polycystic Ovary Syndrome: A Common Reproductive and Metabolic Disorder Necessitating Early Recognition and Treatment
- Androgen physiology and the cutaneous pilosebaceous unit.
- 5α‐Reductase inhibitors and prostatic disease
- Comparative Analysis of Machine Learning Algorithms in Diagnosis of Polycystic Ovarian Syndrome
- Clinical Case Seminar: Postmenopausal androgen excess-challenges in diagnostic work-up and management of ovarian thecosis
- Polycystic Ovary Syndrome (PCOS) and Fertility
- Diagnosis and Management of Polycystic Ovary Syndrome in Adolescent Girls
- Ovarian morphology and prevalence of polycystic ovary syndrome in reproductive aged women with or without mild acne
- Female Adolescent Hair Disorders
- Antiandrogen Therapy for Skin and Hair Disease
- Novel inhibitors of 5α-reductase
- Current Aspects of Antiandrogen Therapy in Women
- Acne neonatorum and Familial Hyperandrogenism
- Randomized clinical trial of astaxanthin supplement on serum inflammatory markers and ER stress‐apoptosis gene expression in PBMCs of women with PCOS
- An osteopontin‐derived peptide inhibits human hair growth at least in part by decreasing fibroblast growth factor‐7 production in outer root sheath keratinocytes
- The Polycystic Ovary Syndrome Health-Related Quality-of-Life Questionnaire: Confirmatory Factor Analysis
- Correlation of skin changes with hormonal changes in polycystic ovarian syndrome: A cross-sectional study clinical study
- Polycystic ovary syndrome and the differential diagnosis of hyperandrogenism
- Current recommendations for the diagnostic evaluation and follow-up of patients presenting with symptomatic polycystic ovary syndrome
- Photo-assisted epilation — review and personal observations